Ignite Creation Date:
2025-12-24 @ 6:55 PM
Ignite Modification Date:
2026-01-01 @ 6:40 PM
Study NCT ID:
NCT00258557
Status:
COMPLETED
Last Update Posted:
2013-06-26
First Post:
2005-11-22
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
TMC114-C211: Trial of an Investigational Protease Inhibitor TMC114 With Ritonavir ("TMC114/r") in HIV-1 Infected Patients Who Have Never Been Treated With Antiretroviral Medications.
Sponsor:
Tibotec Pharmaceuticals, Ireland
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-09
Start Date Type:
None
Primary Completion Date:
2007-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-05
Completion Date Type:
ACTUAL
First Submit Date:
2005-11-22
First Submit QC Date:
None
Study First Post Date:
2005-11-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-06-25
Last Update Post Date:
2013-06-26
Last Update Post Date Type:
ESTIMATED